Proactive Investors - Run By Investors For Investors

IQ-AI on track to double sales in 2019 as it inks deal with CorTechs Labs

IQ-AI Limited’s (LON:IQAI) David Smith caught up with Proactive London's Andrew Scott after announcing that Imaging Biometrics has signed a non-exclusive business development and sales deal with brain analysis firm CorTechs Labs.

Smith says the deal gives them extended and immediate sales representation in the US and other international markets.

He adds that product sales have continued to accelerate in 2019 and as a result they're expecting full year 2019 numbers to be more than double those for 2018.

 
Meet Clinigen Group PLC, MaxCyte, Cello Health PLC, Oncimmune and Silence Therapeutics PLC at our event, London , 11 July 2019. Register here »
View full IQAI profile View Profile

IQ-AI Limited Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use